X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-05-21 | PHAT | Topper James N | Dir | P - Purchase | $3.86 | +3,780 | 5,922,827 | 0% | +$14,609 | ||||||
| M | 2025-05-13 | PHAT | Topper James N | Dir | P - Purchase | $3.30 | +7,420 | 5,919,047 | 0% | +$24,462 | |||||
| M | 2025-05-09 | PHAT | Topper James N | Dir | P - Purchase | $3.17 | +48,203 | 5,911,627 | +1% | +$152,917 | |||||
| M | 2025-05-06 | PHAT | Parikh Asit | Dir | P - Purchase | $2.50 | +10,000 | 95,500 | +12% | +$24,985 | |||||
2025-04-07 | PHAT | Henderson Molly | CFO, CBO | S - Sale | $4.55 | -3,678 | 91,779 | -4% | -$16,740 | ||||||
2025-03-13 | PHAT | Parikh Asit | Dir | P - Purchase | $4.42 | +10,000 | 85,500 | +13% | +$44,200 | ||||||
2025-01-21 | PHAT | Henderson Molly | CFO, CBO | S - Sale | $6.59 | -6,583 | 95,457 | -6% | -$43,371 | ||||||
2025-01-21 | PHAT | Nabulsi Azmi | COO | S - Sale | $6.59 | -7,886 | 1,022,669 | -1% | -$51,957 | ||||||
2025-01-21 | PHAT | Curran Terrie | Pres, Chief Exec | S - Sale | $6.59 | -19,109 | 364,305 | -5% | -$125,884 | ||||||
2024-12-19 | PHAT | Nabulsi Azmi | COO | S - Sale | $8.00 | -1,118 | 1,028,582 | 0% | -$8,944 | ||||||
2024-12-19 | PHAT | Henderson Molly | CFO, CBO | S - Sale | $8.00 | -1,291 | 100,067 | -1% | -$10,328 | ||||||
2024-12-13 | PHAT | Karbe Frank | Dir | P - Purchase | $7.93 | +12,500 | 57,000 | +28% | +$99,084 | ||||||
2024-12-13 | PHAT | Parikh Asit | Dir | P - Purchase | $8.12 | +10,000 | 75,500 | +15% | +$81,248 | ||||||
2024-07-15 | PHAT | Nabulsi Azmi | COO | S - Sale | $11.72 | -10,901 | 1,029,700 | -1% | -$127,760 | ||||||
2024-07-15 | PHAT | Henderson Molly | CFO, CBO | S - Sale | $11.72 | -4,325 | 101,358 | -4% | -$50,689 | ||||||
2024-07-15 | PHAT | Curran Terrie | Pres, Chief Exec | S - Sale | $11.72 | -33,848 | 381,574 | -8% | -$396,699 | ||||||
2024-04-08 | PHAT | Henderson Molly | CFO, CBO | S - Sale | $11.10 | -3,435 | 97,174 | -3% | -$38,129 | ||||||
2024-03-22 | PHAT | Curran Terrie | Pres, Chief Exec | S - Sale | $9.11 | -16,851 | 414,624 | -4% | -$153,513 | ||||||
2024-01-24 | PHAT | Takeda Pharmaceutical Co Ltd | 10% | S - Sale | $8.10 | -3,703,703 | 3,755,583 | -50% | -$29,999,994 | ||||||
| D | 2024-01-19 | PHAT | Henderson Molly | CFO, CBO | S - Sale+OE | $7.75 | -6,307 | 100,609 | -6% | -$48,900 | |||||
2023-11-20 | PHAT | Henderson Molly | CFO, CBO | S - Sale | $7.24 | -2,127 | 104,195 | -2% | -$15,403 | ||||||
| M | 2023-11-06 | PHAT | Parikh Asit | Dir | P - Purchase | $7.81 | +7,500 | 55,000 | +16% | +$58,580 | |||||
2023-11-01 | PHAT | Henderson Molly | CFO, CBO | S - Sale | $8.88 | -12,492 | 106,322 | -11% | -$110,871 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |